| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01477292 |
| P953 | full work available at URL | http://link.springer.com/article/10.1007/BF01477292/fulltext.html |
| http://link.springer.com/content/pdf/10.1007/BF01477292 | ||
| http://link.springer.com/content/pdf/10.1007/BF01477292.pdf | ||
| P698 | PubMed publication ID | 205705 |
| P2093 | author name string | H. W. Seyberth | |
| P2860 | cites work | Pharmacological Reviews | Q2085079 |
| Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets | Q24564188 | ||
| Advances in cyclic nucleotide research | Q27708852 | ||
| Advances in prostaglandin and thromboxane research | Q27708870 | ||
| The effect of parathyroid hormone on the concentration of adenosine 3',5'-monophosphate in skeletal tissue in vitro | Q68743728 | ||
| Selective inhibition by mepacrine of the release of "rabbit aorta contracting substance" evoked by the administration of bradykinin | Q68764240 | ||
| Inhibition of prostaglandin synthesis in man | Q69389919 | ||
| Nonparathyroid Humoral Hypercalcemia in Patients with Neoplastic Diseases | Q69540116 | ||
| Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma | Q69569724 | ||
| The influence of prostaglandin metabolites on the uterine response to PGF2α. A clinical and pharmacokinetic study | Q69755086 | ||
| Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease | Q69771320 | ||
| The differential diagnosis of hypercalcemia | Q70371384 | ||
| On the Metabolism of Prostaglandins E1 and E2 in Man | Q70618308 | ||
| On the metabolism of prostaglandin F 2 in female subjects. II. Structures of six metabolites | Q70641301 | ||
| Significance of phospholipase A for prostaglandin formation | Q71066953 | ||
| Metabolism of prostaglandin E2 in guinea pig liver. II. Pathways in the formation of the major metabolites | Q71757721 | ||
| Production of parathyroid hormone by nonparthyroid tumors | Q72207560 | ||
| Phospholipid precursors of prostaglandins | Q72217755 | ||
| The action of prostaglandin synthetase on 2-arachidonyl-lecithin | Q72217759 | ||
| The Biological Activities of Three Metabolites of Prostaglandin E1 | Q72883532 | ||
| Prostaglandins | Q93493878 | ||
| Klinische Wochenschrift | Q27711855 | ||
| An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation | Q28244623 | ||
| Quantifications of the major urinary metabolite of the E prostaglandins by mass spectrometry: evaluation of the method's application to clinical studies | Q28328935 | ||
| Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides | Q28330215 | ||
| Preparation and quantitation of urinary metabolites of prostaglandin F2α by radioimmunoassay | Q28338294 | ||
| Letter: Indomethacin-responsive hypercalcemia | Q28339144 | ||
| Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides | Q28619497 | ||
| Detection and Isolation of an Endoperoxide Intermediate in Prostaglandin Biosynthesis | Q28622625 | ||
| Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation | Q28622645 | ||
| Isolation and properties of intermediates in prostaglandin biosynthesis | Q28622716 | ||
| Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs | Q29617192 | ||
| Effect of thyrocalcitonin on adenosine 3':5'-cyclic phosphate formation by rat kidney and bone | Q33690808 | ||
| Prostaglandin in Calcium and Bone Metabolism | Q34033887 | ||
| Effects of parathyroid hormone on renal function | Q34036810 | ||
| Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer | Q34064902 | ||
| The chloride-phosphate ratio in hypercalcemia | Q34209547 | ||
| Distribution of prostaglandin E 9-KETOREDUCTASE AND TYPES I and II 15-hydroxyprostaglandin dehydrogenase in swine kidney medulla and cortex | Q34330258 | ||
| Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism | Q34463848 | ||
| Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments | Q34499927 | ||
| Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids | Q35003224 | ||
| Prostaglandin Endoperoxides. A New Concept Concerning the Mode of Action and Release of Prostaglandins | Q35127571 | ||
| Comparative bioassay of prostaglandin E2 and its three pulmonary metabolites | Q35175100 | ||
| Effect of osteoclast activating factor from human leukocytes on bone metabolism | Q35195385 | ||
| Parathyroid hormone secretion in vivo. Demonstration of a calcium-independent nonsuppressible component of secretion | Q35198710 | ||
| Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone | Q35573411 | ||
| Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man. | Q35581901 | ||
| Effects of parathyroid hormone on plasma and urinary adenosine 3′,5′-monophosphate in man | Q35582246 | ||
| Parathyroid Hormone in Human Plasma: IMMUNOCHEMICAL CHARACTERIZATION AND BIOLOGICAL IMPLICATIONS. | Q35898746 | ||
| Parathyroid function and the renal excretion of 3'5'-adenylic acid | Q35974238 | ||
| The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer | Q36040241 | ||
| Changes in bone and bone marrow of rabbits bearing the VX-2 carcinoma. A comparison of local and distant effects | Q36077134 | ||
| Complement-dependent stimulation of prostaglandin synthesis and bone resorption | Q47851391 | ||
| Prostaglandins: Effect on plasma calcium concentration | Q47974851 | ||
| On the metabolism of prostaglandins by rat brain homogenate | Q48363589 | ||
| Prostaglandin production by mouse fibrosarcoma cells in culture: Inhibition by indomethacin and aspirin | Q52831705 | ||
| Control by TSH of a phospholipase A 2 activity, a limiting factor in the biosynthesis of prostaglandins in the thyroid. | Q53706841 | ||
| Quantitative studies on prostaglandin synthesis in man. 3. Excretion of the major urinary metabolite of prostaglandins F 1 alpha and F 2 alpha during pregnancy. | Q53767279 | ||
| Evidence for the secretion of an osteoclast stimulating factor in myeloma. | Q53791263 | ||
| Calcitonin and the formation of 3',5'-AMP in bone and kidney. | Q53903636 | ||
| Prostaglandins and the Hypercalcemia of Cancer | Q54247372 | ||
| Hypercalcemia in bronchogenic carcinoma. A prospective study of 200 patients. | Q54462980 | ||
| Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia, and bronchogenic carcinoma. | Q54683888 | ||
| Some problems of hyperparathyroidism. | Q55424207 | ||
| Hyperparathyroidism associated with malignant tumors of nonparathyroid origin | Q57268299 | ||
| Mechanisms of bone destruction in the development of skeletal metastases | Q59070111 | ||
| Selective Passage of Prostaglandins across the Lung | Q59081317 | ||
| Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins | Q59081584 | ||
| Letter: Indomethacin in hypercalcaemia | Q66701754 | ||
| Proceedings: Lack of hypercalcaemia on infusing prostaglandin E2 to rats, argues against its suggested role in the 'non-parathyroid hypercalcaemic tumour' syndrome | Q66913636 | ||
| The removal and metabolism of prostaglandin E1 by rabbit lung | Q66937803 | ||
| Intravenous Infusion of Prostaglandin E2Raises Plasma Calcium Concentration in the Rat* | Q66943667 | ||
| Hypercalcemia and tumor-prostaglandins: The VX2 carcinoma model in the rabbit | Q66947173 | ||
| Elevated Prostaglandins and Suppressed Parathyroid Hormone Associated with Hypercalcemia and Renal Cell Carcinoma | Q66958556 | ||
| Biological activities of prostaglandin analogues and metabolites on bone in organ culture | Q67011629 | ||
| Editorial: Prostaglandins, hypercalcemia and cancer | Q67328898 | ||
| Prostaglandin: increased production by renal cell carcinoma | Q67370879 | ||
| Hypercalcitonemia in bronchogenic cancer. Evidence for thyroid origin of the hormone | Q67430036 | ||
| Effects of hydrocortisone on the hypercalcemia and plasma levels of 13,14-dihydro-15-keto-prostaglandin E2 in mice bearing the HSDM1 fibrosarcoma | Q67546873 | ||
| Prostaglandin-mediated hypercalcemia in the VX2 carcinoma-bearing rabbit | Q67663369 | ||
| Hormonal control of bone collagen synthesis in vitro: effects of parathyroid hormone and calcitonin | Q67768855 | ||
| Human breast tumour-induced osteolysis and prostaglandins | Q67775518 | ||
| Determination of 15-keto-13,14-dihydro-metabolites of PGE2 and PGF2alpha in plasma using high performance liquid chromatography and gas chromatography-mass spectrometry | Q67799260 | ||
| Prostaglandin endoperoxide analogues and prostaglandid D2 as substrates of human placental 15-hydroxy prostaglandin dehydrogenase | Q67812024 | ||
| Radioimmunoassay for urinary metabolites of prostaglandin F2alpha | Q67842197 | ||
| Plasma prostaglandin E in patients with cancer with and without hypercalcemia | Q68213923 | ||
| Failure of indomethacin to reduce hypercalcemia in patients with breast cancer | Q68220952 | ||
| Hypercalcemia and increased parathyroid-hormone activity in a primary hepatoma. Studies before and after hepatic transplantation | Q68606087 | ||
| Prostaglandins: stimulation of bone resorption in tissue culture | Q68608873 | ||
| [Determination of renal cyclic adenosine 3',5'-monophosphate excretion for diagnosis of primary hyperparathyroidism] | Q68684617 | ||
| Effect of parathormone and cyclic adenosine monophosphate on renal bicarbonate reabsorption | Q68705136 | ||
| Inhibition of bone collagen synthesis by prostaglandin E2 in organ culture | Q68708650 | ||
| IMMUNOCHEMICAL IDENTIFICATION OF PARATHYROID HORMONE IN NON-PARATHYROID NEOPLASMS ASSOCIATED WITH HYPERCALCEMIA | Q36267107 | ||
| Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer | Q36272220 | ||
| Bronchial carcinoma and hypercalcaemia | Q36551226 | ||
| The chemical structure of prostaglandin X (prostacyclin) | Q39128911 | ||
| Letter: Indomethacin in hypercalcaemia | Q39324753 | ||
| Breast cancer, prostaglandins, and bone metastases | Q39328872 | ||
| Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin | Q39369175 | ||
| Letter: Prostaglandins, indomethacin and hypercalcemia in neoplastic disease | Q39731013 | ||
| Drugs for disorders of bone: pharmacological and clinical considerations | Q39889037 | ||
| Structure, synthesis, and mechanism of action of parathyroid hormone. | Q39897293 | ||
| Clinical studies and applications of cyclic nucleotides | Q39899443 | ||
| Parathyroid hormone and calcitonin regulation of renal function | Q39902848 | ||
| Selective Proteolysis of the Receptor for Parathyroid Hormone in Renal Corte1 | Q39916616 | ||
| Bone resorption in tissue culture and its relevance to periodontal disease | Q39932285 | ||
| Selective proteolysis of the receptor for parathyroid hormone in skeletal tissue | Q39944325 | ||
| Prostaglandin mediation of collagenase-induced bone resorption | Q40010414 | ||
| Effects of prostaglandins and other drugs on the cyclic AMP content of cultured bone cells | Q40016990 | ||
| Pseudohyperparathyroidism | Q40034789 | ||
| Characterization of the group of patients with the hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors | Q40053866 | ||
| Parathyroid Hormone- and Prostaglandin E1-Response in a Selected Population of Bone Cells After Repeated Subculture and Storage at ‒80 C | Q40057346 | ||
| Rat osteogenic sarcoma cells: Effects of some prostaglandins, their metabolites and analogues on cyclic AMP production | Q40075591 | ||
| Inhibition of carbonic anhydrase by parathyroid hormone and cyclic AMP in rat renal cortex in vitro | Q40303395 | ||
| Effect of prostaglandin E 1 on certain renal actions of parathyroid hormone | Q40326565 | ||
| Plasma prostaglandins in hypercalcemic patients with neoplastic disease | Q41052281 | ||
| Plasma concentrations of 13,14-dihydro-15-keto-prostaglandin E2 in rabbits bearing the VX2 carcinoma: effects of hydrocortisone and indomethacin | Q41055947 | ||
| Value of plasma chloride concentration and acid-base status in the differential diagnosis of hyperpara-thyroidism from other causes of hypercalcaemia | Q41253369 | ||
| Metabolism of thromboxane B2 in the cynomolgus monkey | Q41254313 | ||
| Identification of the major urinary metabolite of thromboxane B2 in the monkey | Q41254326 | ||
| Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig | Q41825377 | ||
| Indomethacin-Responsive Hypercalcemia in a Patient with Renal-Cell Adenocarcinoma | Q42235890 | ||
| Metabolism of prostaglandin E2 in guinea pig liver. I. Identification of seven metabolites | Q42238890 | ||
| Influence of various hormones on formation of adenosine-3':5'-monophosphate and guanosine-3':5'-monophosphate by particulate preparations from rat kidney | Q43411385 | ||
| Hypercalcemic VX-2 carcinoma in rabbits: a clinicopathologic study | Q43529832 | ||
| Prostaglandin metabolism. I. Cytoplasmic reduced nicotinamide adenine dinucleotide phosphate-dependent and microsomal reduced nicotinamide adenine dinucleotide-dependent prostaglandin E 9-ketoreductase activities in monkey and pigeon tissues | Q43729460 | ||
| Some thoughts on the nature of ectopic parathyroid hormones | Q43897675 | ||
| Endogenous levels of 15-keto-dihydro-prostaglandins in human plasma. Parameters for monitoring prostaglandin synthesis | Q43908862 | ||
| Increased arachidonate in lipids after administration to man: Effects on prostaglandin biosynthesis | Q43917539 | ||
| Effect of prostaglaidin endoperoxides and metabolites on bone resorption in vitro | Q44165325 | ||
| Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis | Q44359551 | ||
| Inactivation of Prostaglandins by the Lungs | Q44526045 | ||
| Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells | Q44635468 | ||
| Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate | Q45117286 | ||
| Bone destruction by breast tumours | Q45205883 | ||
| The importance of phospholipase-A2 in prostaglandin biosynthesis | Q45221274 | ||
| Drugs which inhibit prostaglandin biosynthesis | Q45293232 | ||
| Prostaglandins as Mediators of Hypercalcemia Associated with Certain Types of Cancer | Q45300377 | ||
| Quantitative analysis of prostaglandins and thromboxanes by mass spectrometric methods | Q45382954 | ||
| Stimulation of bone resorption by various prostaglandins in organ culture | Q45415166 | ||
| Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs | Q46576516 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | molecular medicine | Q3523816 |
| P304 | page(s) | 373-387 | |
| P577 | publication date | 1978-04-01 | |
| 1978-04-15 | |||
| P1433 | published in | Klinische Wochenschrift | Q27711855 |
| P1476 | title | Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome | |
| Prostaglandin-mediated hypercalcemia: A paraneoplastic syndrome | |||
| P478 | volume | 56 |
| Q70232141 | Ametantrone inhibits prostaglandin — mediated resorption in bone organ culture |
| Q46394413 | Curcumin diminishes human osteoclastogenesis by inhibition of the signalosome-associated I kappaB kinase |
| Q66952191 | Effects of 2-aminomethyl-4-t-butyl-6-iodophenol (MK-447) on granulomatous inflammation: lack of correlation with changes in levels of prostaglandin-like material |
| Q60681312 | Non-opioid analgesics in cancer pain relief |
| Q35992265 | Osteoclasts and the resorption of bone by transplanted mammary carcinoma in rats |
| Q40131361 | Polyamines in Mammalian Tumors Part ii |
| Q70970021 | Primary squamous cell carcinoma of the thyroid associated with marked leukocytosis and hypercalcemia |
| Q36044312 | Prostaglandin E production and hypercalcaemia in rats bearing the Walker carcinosarcoma |
Search more.